Location History:
- San Diego, CA (US) (1996 - 2001)
- Hyvinkaa, FI (2006)
Company Filing History:
Years Active: 1996-2006
Title: The Innovations of Erkki Koivunen
Introduction
Erkki Koivunen is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of integrin-binding peptides. With a total of six patents to his name, Koivunen's work has the potential to impact various medical applications.
Latest Patents
One of Koivunen's latest inventions involves novel integrin-binding peptides. These peptides are designed to bind to α- of α-containing integrins, exhibiting high binding affinity. They contain specific sequence motifs such as RXETXWX and RGDGX, where X represents an amino acid with a hydrophobic, aromatic side chain. The peptides demonstrate their highest binding affinity when they adopt a conformationally stabilized configuration. Additionally, another patent focuses on peptides that have specificity for fibronectin-binding and vitronectin-binding integrins. These peptides can interfere with extracellular matrix protein binding to integrins, block cell attachment to extracellular matrix proteins, and promote cell attachment when coated onto surfaces.
Career Highlights
Throughout his career, Koivunen has worked with notable organizations, including the La Jolla Cancer Research Foundation and the Burnham Institute. His research has contributed to advancements in understanding cell interactions and the role of integrins in various biological processes.
Collaborations
Koivunen has collaborated with esteemed colleagues, including Erkki I Ruoslahti, further enhancing the impact of his research in the scientific community.
Conclusion
Erkki Koivunen's innovative work in integrin-binding peptides showcases his dedication to advancing biotechnology. His patents reflect a commitment to improving medical applications and understanding cellular interactions.